ClinicalTrials.Veeva

Menu

Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients

A

Asan Medical Center

Status

Completed

Conditions

Achalasia
Alacrima

Study type

Observational

Funder types

Other

Identifiers

NCT00856921
AAASachalasia

Details and patient eligibility

About

The AAAS gene has been known to cause achalasia, alacrima, adrenal abnormalities and a progressive neurological syndrome. A considerable proportion of achalasia patients have been known to show alacrima (decreased secretion of tears). However, the genetic mechanism between achalasia and alacrima has not been defined yet. The investigators postulated that some proportions of early-onset achalasia could be correlated with AAAS gene; thus, the investigators aimed to investigate the relationship between the AAAS gene and early-onset achalasia.

Enrollment

19 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • early age onset
  • primary achalasia patient
  • less than 35 years old

Exclusion criteria

  • secondary achalasia patients

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems